The influence of corporate market power on health: exploring the structure-conduct-performance model from a public health perspective
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Background: The detrimental impact of dominant corporations active in health-harming commodity industries is well recognised. However, to date, existing analyses of the ways in which corporations influence health have paid limited attention to corporate market power. Accordingly, the public health implications of concentrated market structures, the use of anti-competitive market strategies, and the ways in which market power mediates the allocation and distribution of resources via market systems, remain relatively unexplored. To address this gap, this paper aimed to identify and explore key literature that could inform a comprehensive framework to examine corporate market power from a public health perspective. The ultra-processed food (UPF) industry was used to provide illustrative examples. Methods: A scoping review of a diverse range of literature, including Industrial Organization, welfare economics, global political economy and antitrust policy, was conducted to identify important concepts and metrics that could be drawn upon within the field of public health to understand and explore market power. The Structure-Conduct-Performance (SCP) model, a guiding principle of antitrust policy and the regulation of market power, was used as an organising framework. Results: We described each of the components of the traditional SCP model and how they have historically been used to assess market power through examining the interrelations between the structure of industries and markets, the conduct of dominant firms, and the overall ability of markets and firms to efficiently allocate and distribute the scarce resources. Conclusion: We argue that the SCP model is well-placed to broaden public health research into the ways in which corporations influence health. In addition, the development of a comprehensive framework based on the key findings of this paper could help the public health community to better engage with a set of policy and regulatory tools that have the potential to curb the concentration of corporate power for the betterment of population health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Theory of Economic Regulation
Stigler, G. J. (1971) · The Bell Journal of Economics and Management Science · doi:10.2307/3003160 · Cited by 8,098 · cited 1×
“negative externalities) are not addressed [29, 30].”
Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., Lincoln, P., & Casswell, S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62089-3 · Cited by 1,663 · cited 1×
“Although not typically framed in this way, the CDoH literature contains a vast amount of evidence that describes, and, in some cases, quantifies, a diverse range of social and ecological-related negative externalities generated by a number of health-harming industries, including the UPF industry [2, 32, 143, 144].”
BackgroundChapter 17 Empirical studies of industries with market power
Bresnahan, T. F. (1989) · Handbook of Industrial Organization · doi:10.1016/s1573-448x(89)02005-4 · Cited by 1,271
Baker, P., Machado, P., Santos, T., Sievert, K., Backholer, K., Hadjikakou, M., Russell, C., Huse, O., Bell, C., Scrinis, G., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13126 · Cited by 1,194
Self-citationMonteiro, C. A., Levy, R. B., Claro, R. M., de Castro, I. R. R., & Cannon, G. (2010) · Public Health Nutrition · doi:10.1017/s1368980010003241 · Cited by 1,060
Fiolet, T., Srour, B., Sellem, L., Kesse-Guyot, E., Allès, B., Méjean, C., Deschasaux, M., Fassier, P., Latino-Martel, P., Beslay, M., et al. (2018) · BMJ · doi:10.1136/bmj.k322 · Cited by 1,057
The age of responsibilization: on market-embedded morality
Shamir, R. (2008) · Economy and Society · doi:10.1080/03085140701760833 · Cited by 1,025 · cited 1×
“Externalised costs – commonly referred to as negative externalities – essentially occur when firms are not held financially accountable for the collateral damage they cause to society and the environment [69, 142].”
BackgroundAnticompetitive Effects of Common Ownership
AZAR, J., SCHMALZ, M. C., & TECU, I. (2018) · The Journal of Finance · doi:10.1111/jofi.12698 · Cited by 980
Srour, B., Fezeu, L. K., Kesse-Guyot, E., Allès, B., Méjean, C., Andrianasolo, R. M., Chazelas, E., Deschasaux, M., Hercberg, S., Galan, P., et al. (2019) · BMJ · doi:10.1136/bmj.l1451 · Cited by 955
The commercial determinants of health
Kickbusch, I., Allen, L., & Franz, C. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30217-0 · Cited by 782
Cited by
Wood, B., Williams, O., Baker, P., & Sacks, G. (2023) · Journal of Agrarian Change · doi:10.1111/joac.12545 · Cited by 47
Self-citationSlater, S., Lawrence, M., Wood, B., Serodio, P., & Baker, P. (2024) · Globalization and Health · doi:10.1186/s12992-024-01020-4 · Cited by 42
Self-citationHuse, O., Reeve, E., Bell, C., Sacks, G., Baker, P., Wood, B., & Backholer, K. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-010386 · Cited by 36
Self-citationGaucher-Holm, A., Wood, B., Sacks, G., & Vanderlee, L. (2023) · Globalization and Health · doi:10.1186/s12992-023-00917-w · Cited by 11
Metadata
- Authors
- Wood, B., Williams, O., Baker, P., Nagarajan, V., & Sacks, G.
- Venue
- Globalization and Health
- Published
- 2021-04-06
- Volume
- 17
- Issue
- 1
- Pages
- 41-41
- ISSN
- 1744-8603 (ISSN-L)
- OpenAlex
- W3142275185
- Cited by
- 35
- References
- 21
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The influence of corporate market power on health: exploring the structure-conduct-performance model from a public health perspective. https://app.cochat.ai/papers/10.1186/s12992-021-00688-2
- The paper
- Wood, B., Williams, O., Baker, P., Nagarajan, V., & Sacks, G. (2021). The influence of corporate market power on health: exploring the structure-conduct-performance model from a public health perspective. Globalization and Health. https://doi.org/10.1186/s12992-021-00688-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.